The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk
Paolina Crocco, Alberto Montesanto, Rossella La Grotta, Ersilia Paparazzo, Luca Soraci, Serena Dato, Giuseppe Passarino, Giuseppina Rose, Konrad Huppi · 2024
Read The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk by Paolina Crocco, Alberto Montesanto, Rossella La Grotta, Ersilia Paparazzo, Luca Soraci, Serena Dato, Giuseppe Passarino, Giuseppina Rose, Konrad Huppi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641116.txt.
Description
Heart and blood-vessel disease is the world's great killer, and Paolina Crocco and co-authors test whether tiny muscle-related RNA molecules in blood track that risk. These myomiRs — three of them, named miR-133a-3p, miR-133b, and miR-206 — are made mainly in heart and skeletal muscle. The team compared their levels in patients with several forms of cardiovascular disease and in controls, recruiting through nursing homes in Calabria, Italy.
One molecule ran low in heart failure and another in stroke, and two were lower across cardiovascular patients overall. Yet the markers separated patients from controls only weakly, so their diagnostic value looks limited. Computer analysis of their gene targets placed them inside key cardiovascular processes. The authors say the findings hint at a real role for these molecules in vessel and heart injury, while stressing that more work is needed before any clinical use.
Catalog record
| CREATOR | Paolina Crocco, Alberto Montesanto, Rossella La Grotta, Ersilia Paparazzo, Luca Soraci, Serena Dato, Giuseppe Passarino, Giuseppina Rose, Konrad Huppi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |